Skip to content
Catalyst

Bifidobacterium longumFinding

Bifidobacterium longum has no detected effect on body mass

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“As shown in Table 2, both the BL21 group (P = 0.02) and placebo group (P = 0.01) demonstrated significant body weight reductions, with no statistically significant intergroup difference observed (P = 0.81).”
Quoted verbatim from Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study.
This finding among the 85 findings on its endpoint

Bifidobacterium longum

Body mass

no difference found

Who
Overweight and obese adults aged 18-65 (BMI above 24 kg/m2); per-protocol set of 33 per arm; placebo was maltodextrin
Dose studied
once daily for 8 weeks, 2 × 1010 CFU/day with 3 g maltodextrin per day, oral powder

Moderate evidencePMID 40676704 · 2025

02 · The study

Study
RCT
Duration
8 weeks

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GAEH1BM0KBBDZXWPCB7VKK